BioSURE is a UK company specializing in the provision of rapid in-vitro diagnostic testing solutions.…
Browsing: antibody
In a study of 19 patients with glioblastoma, progression-free survival increased from 6 months to 19 months.
Micromet has licensed one of its cancer-fighting antibody candidates to Sanofi-Aventis in a $477 million deal.